Health Economic Modelling

Crystallise offers a flexible, evidence-based, and clinically informed modelling approach for even the most complex diseases and health outcomes.

Case Studies

Crystallise partnered with a national healthcare provider to assess population-based interventions for diabetes, focusing on key outcomes such as disease, complications, and lifestyle biometrics (e.g., cholesterol). We built a stochastic model of diabetes to estimate intervention effects, associated costs, and outcomes, to identify risks and potential returns on investment, supporting the healthcare provider in optimising patient care and resource allocation.

Crystallise’s Health Economic Modelling Service offers the pharmaceutical and healthcare industries a flexible approach to complex disease modelling and evidence-based research. Our clinical expertise and modelling capabilities allow us to provide comprehensive assessments of the impact of interventions on key health outcomes. We collaborate with economic modelling experts to ensure you receive the full range of required experience and competencies for Heath Technology Assessments.

Get in Touch

17 High Street,
SS17 0HD



Company No: 7980921
Data Protection Act Registration No: Z3363643
VAT No: 190 8750 82

© Crystallise 2023

Crystallise Policy

Crystallise Carbon Policy